As previously reported, Wolfe Research analyst Doug Schenkel initiated coverage of Agilent with an Outperform rating and $140 price target, citing continued top-tier operational execution and solid management of Street expectations. The firm views the risk/reward as attractive despite broader concerns about headwinds in China and the biotech and pharmaceutical end market, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on A: